Quarterly Statement Of Cash Flows

Daito Pharmaceutical Co., Ltd. - Filing #7579309

Concept 2022-06-01 to
2022-11-30
As at
2022-11-30
As at
2022-05-31
As at
2021-11-30
2021-06-01 to
2021-11-30
As at
2021-05-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,439,000,000 JPY
3,364,000,000 JPY
Interest and dividends received
36,000,000 JPY
33,000,000 JPY
Interest paid
-8,000,000 JPY
-3,000,000 JPY
Income taxes paid
-1,318,000,000 JPY
-1,034,000,000 JPY
Net cash provided by (used in) operating activities
1,141,000,000 JPY
2,407,000,000 JPY
Cash flows from investing activities
Purchase of securities
0 JPY
JPY
Purchase of property, plant and equipment
-1,531,000,000 JPY
-1,454,000,000 JPY
Proceeds from sale of investment securities
JPY
256,000,000 JPY
Other, net
0 JPY
21,000,000 JPY
Net cash provided by (used in) investing activities
-1,545,000,000 JPY
-1,276,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
3,000,000,000 JPY
JPY
Repayments of long-term borrowings
-821,000,000 JPY
-754,000,000 JPY
Purchase of treasury shares
-110,000,000 JPY
0 JPY
Dividends paid
-499,000,000 JPY
-315,000,000 JPY
Net cash provided by (used in) financing activities
1,871,000,000 JPY
-680,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
34,000,000 JPY
-2,000,000 JPY
Net increase (decrease) in cash and cash equivalents
1,501,000,000 JPY
447,000,000 JPY
Cash and cash equivalents
5,882,000,000 JPY
4,381,000,000 JPY
3,820,000,000 JPY
3,372,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.